Evidence map›Paper›PMID 38813805›Full record

ArticleJournal of the American Geriatrics Society2024

Patient perspectives on evidence supporting drug safety and effectiveness: "What does it mean for me?"

Leah Z G Rand, Sarah McGraw, Junyi Wang, Steven Woloshin, Shirley V Wang, Jonathan Darrow, Aaron S Kesselheim

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Geriatrics Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leah Z G RandProgram on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-3262-1584
Sarah McGrawMNW Consulting Group, Portland, Oregon, USA.
Junyi WangProgram on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Steven WoloshinThe Dartmouth Institute, Geisel School of Medicine, Dartmouth, Hanover, New Hampshire, USA.
Shirley V WangHarvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0001-7761-7090
Jonathan DarrowProgram on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-7351-4243
Aaron S KesselheimProgram on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Funding

Understanding effectiveness of new drugs in older adults shortly after market entryR01AG053302 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI WANG, SHIRLEY · 2018 to 2021
$2.0M
NIA NIH HHS 5R01AG053302-04NIA NIH HHS R01 AG053302
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug-Related Side Effects and Adverse ReactionsAgedEvidence-Based MedicineFemaleHumansMale

Identifiers

PMID38813805
PMCPMC11368646

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.